Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

Clinical trial NCT06180499 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06180499
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematological Malignancies Regulatory T Cell Depletion Relapse

Start date: 2024-03-01
Primary completion: 2028-11-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.